TOTAL VOLUME:

$154.8b

24H VOL:

$238,896,186

24H TRANSACTIONS:

2,985,204,718

OPEN INTEREST:

$1,897,934,485

408,127

Markets across

39,552

events

MATCHED EVENTS:

4,429

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Tour
All
Politics
Will Trump formalize a 100% tariff on generic drugs before the midterms?
kalshi

Will Trump formalize a 100% tariff on generic drugs before the midterms?

Volume:
$4,120

Yes

 - Kalshi

Yes - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Nov 3, 2026

Closed: Nov 2, 11:59 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Yes

View
0%
Yes 0¢No 100¢
—
N/A
$4,120
N/A
N/A
$868
6h 2m
No
Total markets: 1

Description

The event centers on whether a specific political figure will enact a significant tariff on imported generic pharmaceutical products through executive action. This would involve establishing a high levy aimed at protecting domestic drug manufacturing. The outcome hinges on such action being taken before a set date in late 2026.

Kalshi

If Donald Trump has taken any executive action establishing a tariff of 100% or greater specifically on imported generic pharmaceutical products before Nov 3, 2026, then the market resolves to Yes.

Frequently asked questions

On Kalshi, the Trump drug tariff market dashboard tracks the current probability that Donald Trump will take executive action to impose a 100% tariff on generic drugs before the midterms. It displays real-time odds, price history, and 24-hour volume of $1. This visualization helps traders monitor sentiment and liquidity shifts as the event date approaches.

This market resolves around Nov 3, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. A formal executive action or official announcement by Trump before the midterms will settle the market; absence of such action by the deadline leads to the opposite result.

Several signals could shift this market before Nov 3, 2026. Key catalysts include official policy statements from the administration, legislative proposals related to pharmaceutical imports, economic reports affecting trade priorities, and major political developments ahead of the midterms. Media coverage and expert commentary may also influence trader sentiment and drive volume changes as the resolution date nears.